Yayın: The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases
Tarih
Kurum Yazarları
Eker, Salih Saygın
Sarandol, Aslı
Akkaya, Cengiz
Sivrioğlu, Enver Yusuf
Kırlı, Selçuk
Yazarlar
Danışman
Dil
Türü
Yayıncı:
Sage Publications
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Özet
QTc interval prolongation may appear as a consequence of both typical and atypical antipsychotic treatments. Ziprasidone, which is effective in treating schizophrenia, is associated with QTc prolongation. Although the prolongation of QTc with ziprasidone treatment is often pronounced, there is a scarce number of cases reported about the relationship between ziprasidone and QTc prolongation. Of the three cases presented in this case series, two cases showed values exceeding 0.50 s with ziprasidone treatment.
Açıklama
Kaynak:
Anahtar Kelimeler:
Konusu
Antipsychotic, QTc prolongation, Ziprasidone, Torsade-de-pointes, Schizoaffective disorder, Antipsychotic-drugs, Acute exacerbation, Double-blind, 160 mg/day, Schizophrenia, Safety, Haloperidol, Management, Neurosciences & neurology, Pharmacology & pharmacy, Psychiatry
Alıntı
Eker, S. S. vd. (2009). "The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases". Journal of Psychopharmacology, 23(8), 993-996.